While the original model for transcellular propagation of soluble tau aggregates is centered on neurons, tau oligomers also accumulate in the brain microvasculature, both in neurodegenerative diseases such as AD and progressive supranuclear palsy (PSP), as wells as in mouse models of AD18. The gene discussed is MAPT; the disease is Alzheimer disease.